These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37079243)

  • 21. Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection.
    Wang S; Liu Y; Guo J; Wang P; Zhang L; Xiao G; Wang W
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus.
    Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Kumar GS; Dubey A; Dwivedi VD; Azhar EI
    Sci Rep; 2023 Sep; 13(1):14570. PubMed ID: 37666979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach.
    Sahu A; Gaur M; Mahanandia NC; Subudhi E; Swain RP; Subudhi BB
    Comput Biol Med; 2023 Jul; 161():106971. PubMed ID: 37211001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel phytochemical inhibitors targeting monkeypox virus thymidine and serine/threonine kinase: integrating computational modeling and molecular dynamics simulation.
    Patel M; Bazaid AS; Azhar EI; Gattan HS; Binsaleh NK; Patel M; Surti M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):13679-13695. PubMed ID: 36852556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinase.
    Rabaan AA; Alwashmi ASS; Mashraqi MM; Alshehri AA; Alawfi A; Alshengeti A; Najim MA; AlShehail BM; AlShahrani AJ; Garout M
    Mol Divers; 2023 Aug; ():. PubMed ID: 37531040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.
    Gupta Y; Maciorowski D; Zak SE; Jones KA; Kathayat RS; Azizi SA; Mathur R; Pearce CM; Ilc DJ; Husein H; Herbert AS; Bharti A; Rathi B; Durvasula R; Becker DP; Dickinson BC; Dye JM; Kempaiah P
    Methods; 2021 Nov; 195():57-71. PubMed ID: 33453392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I.
    Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
    Kandeel M; Al-Nazawi M
    Life Sci; 2020 Jun; 251():117627. PubMed ID: 32251634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus.
    Ali Y; Imtiaz H; Tahir MM; Gul F; Saddozai UAK; Ur Rehman A; Ren ZG; Khattak S; Ji XY
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment.
    Lu J; Xing H; Wang C; Tang M; Wu C; Ye F; Yin L; Yang Y; Tan W; Shen L
    Signal Transduct Target Ther; 2023 Dec; 8(1):458. PubMed ID: 38148355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on monkeypox virus infection: Focusing current treatment and prevention approaches.
    Dhapola R; Kumari S; Sharma P; KumarKushawaha P; HariKrishnaReddy D
    Fundam Clin Pharmacol; 2024 Jun; 38(3):465-478. PubMed ID: 38226405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of
    Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
    Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing FDA-approved drugs for anti-aging therapies.
    Snell TW; Johnston RK; Srinivasan B; Zhou H; Gao M; Skolnick J
    Biogerontology; 2016 Nov; 17(5-6):907-920. PubMed ID: 27484416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying potential monkeypox virus inhibitors: an
    Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
    Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
    Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
    Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
    Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
    [No Abstract]   [Full Text] [Related]  

  • 39. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual screening FDA approved drugs against multiple targets of SARS-CoV-2.
    Liang H; Zhao L; Gong X; Hu M; Wang H
    Clin Transl Sci; 2021 May; 14(3):1123-1132. PubMed ID: 33606912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.